Basic Information
RNALocate ID: RLID:11001483
RNA Symbol: hsa-miR-205-5p
Localization: Microvesicle
RNA Information
RNA Name: hsa-miR-205
RNA ID: miRBase:MIMAT0000266
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 20615901
Tissue/Cell Line: Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549)
Method: Microarray|RT-PCR

Originally published in Nucleic Acids Res. Wang K, et al, 2010. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/)

Description: These observations of miRNA distribution demonstrate that the miRNA export system in the cells must somehow be able to target specific miRNAs to specific extracellular structures, but does not exclusively channel specific miRNAs to a given fraction. There are, however, some miRNAs that are found in the supernatant almost to the exclusion of all other fractions (miR-219 in A549 culture medium, Figure 4b, for example). Another significant observation from this data is that even though we showed that the two cell lines studied here export a similar spectrum of miRNAs (Figure 1b) the distributions of miRNAs from the two cell lines demonstrate clear differences, as shown in Figure 4b and c. For example, miR-145 is present at very low levels in HepG2 derived microvesicles (Figure 4c), while the same miRNA is present at significant levels in both A549 derived microvesicles and exosomes (Figure 4b). On the other hand, there are some miRNAs, notably those that are almost uniformly distributed among the fractions, with the same distribution no matter which cell-line is the source. These observations certainly indicate the degree of complexity of this export system that will bear further investigation. Data are collected from Figure 4.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001645 Cytoplasm Tumor tissues (Head|Neck) 25422181
RLID:01001646 Nucleus Tumor tissues (Head|Neck) 25422181
RLID:11001475 Exosome Urine 26576778
RLID:11001476 Exosome Primary ovarian tumor cells|Serum 18589210
RLID:11001477 Exosome Plasma 19289371
RLID:11001478 Exosome Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) 20615901
RLID:11001479 Exosome Ascites fluid|Pleural effusion 21601258
RLID:11001480 Exosome Breast milk 22211110
RLID:11001481 Exosome Brain tissue 23382797
RLID:11001482 Exosome Plasma 23663360
RLID:11001484 Microvesicle Seminal plasma 23539611
RLID-D:11000057 Exosome Breast milk|Tongue tissue
RLID-D:11000327 Microvesicle Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-205-5p Splenic marginal zone lymphoma MNDR-E-MI-27139
MNDR hsa-miR-205-5p High-grade serous ovarian carcinoma MNDR-E-MI-27140
MNDR hsa-miR-205-5p Uterine corpus endometrial carcinoma MNDR-E-MI-27141
MNDR hsa-miR-205-5p Lymphoma MNDR-E-MI-27142
MNDR hsa-miR-205-5p Lymphoma non-hodgkin MNDR-E-MI-27143
MNDR hsa-miR-205-5p Cutaneous t cell lymphoma MNDR-E-MI-27144
MNDR hsa-miR-205-5p Estrogen-receptor positive breast cancer MNDR-E-MI-27145
MNDR hsa-miR-205-5p Estrogen-receptor negative breast cancer MNDR-E-MI-27146
MNDR hsa-miR-205-5p Progesterone-receptor positive breast cancer MNDR-E-MI-27147
MNDR hsa-miR-205-5p Progesterone-receptor negative breast cancer MNDR-E-MI-27148
MNDR hsa-miR-205-5p Her2-receptor positive breast cancer MNDR-E-MI-27149
MNDR hsa-miR-205-5p Triple negative breast cancer MNDR-E-MI-27150
MNDR hsa-miR-205-5p Prostate cancer MNDR-E-MI-27151
MNDR hsa-miR-205-5p Prostate carcinoma MNDR-E-MI-27152
MNDR hsa-miR-205-5p Gastric cancer MNDR-E-MI-27153
MNDR hsa-miR-205-5p Gastric lymphoma MNDR-E-MI-27154
MNDR hsa-miR-205-5p Alzheimer disease MNDR-E-MI-27155
MNDR hsa-miR-205-5p Bladder cancer MNDR-E-MI-27156
MNDR hsa-miR-205-5p Esophageal carcinoma MNDR-E-MI-27157
MNDR hsa-miR-205-5p Head and neck cancer MNDR-E-MI-27158
MNDR hsa-miR-205-5p Hereditary hemorrhagic telangiectasia MNDR-E-MI-27159
MNDR hsa-miR-205-5p Ataxia telangiectasia MNDR-E-MI-27160
MNDR hsa-miR-205-5p Huntington disease MNDR-E-MI-27161
MNDR hsa-miR-205-5p Cardiovascular disease MNDR-E-MI-27162
MNDR hsa-miR-205-5p Lung cancer MNDR-E-MI-27163
MNDR hsa-miR-205-5p Endometrial cancer MNDR-E-MI-27164
MNDR hsa-miR-205-5p Parkinson disease MNDR-E-MI-27165
MNDR hsa-miR-205-5p Machado-joseph disease MNDR-E-MI-27166
MNDR hsa-miR-205-5p Breast cancer MNDR-E-MI-27167
MNDR hsa-miR-205-5p Aggressive squamous cell carcinoma MNDR-E-MI-27168
MNDR hsa-miR-205-5p Thyroid cancer MNDR-E-MI-27169
MNDR hsa-miR-205-5p Pituitary neoplasms MNDR-E-MI-27170
MNDR hsa-miR-205-5p Malignant mesothelioma MNDR-E-MI-27171
MNDR hsa-miR-205-5p Pancreatic cancer MNDR-E-MI-27172
MNDR hsa-miR-205-5p Melanoma MNDR-E-MI-27173
MNDR hsa-miR-205-5p Colon cancer MNDR-E-MI-27174
MNDR hsa-miR-205-5p Multiple sclerosis relapsing-remitting MNDR-E-MI-27175
MNDR hsa-miR-205-5p Ovarian cancer MNDR-E-MI-27176
MNDR hsa-miR-205-5p Prostate adenocarcinoma MNDR-E-MI-27177
MNDR hsa-miR-205-5p Renal cancer MNDR-E-MI-27178
MNDR hsa-miR-205-5p Endometrial carcinoma MNDR-E-MI-27179
MNDR hsa-miR-205-5p Carcinoma ductal breast MNDR-E-MI-27180
MNDR hsa-miR-205-5p Balkan nephropathy MNDR-E-MI-27181
MNDR hsa-miR-205-5p Glioblastoma MNDR-E-MI-27182
MNDR hsa-miR-205-5p Glioma MNDR-E-MI-27183
MNDR hsa-miR-205-5p Amyotrophic lateral sclerosis MNDR-E-MI-27184
MNDR hsa-miR-205-5p Osteosarcoma MNDR-E-MI-27185
MNDR hsa-miR-205-5p Breast carcinoma MNDR-E-MI-27186
MNDR hsa-miR-205-5p Uterine cancer MNDR-E-MI-27187
MNDR hsa-miR-205-5p Cervical adenocarcinoma MNDR-E-MI-27188
MNDR hsa-miR-205-5p Gastric adenocarcinoma MNDR-E-MI-27189
MNDR hsa-miR-205-5p Cervical squamous cell carcinoma MNDR-E-MI-27190
MNDR hsa-miR-205-5p Pituitary adenoma MNDR-E-MI-27191
MNDR hsa-miR-205-5p Lung squamous cell carcinoma MNDR-E-MI-27192
MNDR hsa-miR-205-5p Carcinoma lung non-small-cell MNDR-E-MI-27193
MNDR hsa-miR-205-5p Lung adenocarcinoma MNDR-E-MI-27194
MNDR hsa-miR-205-5p Thyroid carcinoma MNDR-E-MI-27195
MNDR hsa-miR-205-5p Ovarian carcinoma MNDR-E-MI-27196
MNDR hsa-miR-205-5p Bladder urothelial carcinoma MNDR-E-MI-27197
MNDR hsa-miR-205-5p Pancreatic adenocarcinoma MNDR-E-MI-27198
MNDR hsa-miR-205-5p Cervical cancer MNDR-E-MI-27199
MNDR hsa-miR-205-5p Biliary tract cancer MNDR-E-MI-27200
MNDR hsa-miR-205-5p Esophageal cancer MNDR-E-MI-27201
MNDR hsa-miR-205-5p Head and neck squamous cell carcinoma MNDR-E-MI-27202
MNDR hsa-miR-205-5p Breast invasive carcinoma MNDR-E-MI-27203
MNDR hsa-miR-205-5p Hepatocellular carcinoma MNDR-E-MI-27204
MNDR hsa-miR-205-5p B-cell lymphoma MNDR-E-MI-27205
MNDR hsa-miR-205-5p Rheumatoid arthritis MNDR-E-MI-27206
MNDR hsa-miR-205-5p T-cell leukemia MNDR-E-MI-27207
MNDR hsa-miR-205-5p Neuroblastoma MNDR-E-MI-27208
MNDR hsa-miR-205-5p Barrett's adenocarcinoma MNDR-E-MI-27209
MNDR hsa-miR-205-5p Influenza MNDR-E-MI-27210
MNDR hsa-miR-205-5p Burkitt lymphoma MNDR-E-MI-27211
MNDR hsa-miR-205-5p Kb oral cancer MNDR-E-MI-27212
MNDR hsa-miR-205-5p Skin cutaneous melanoma MNDR-E-MI-27213
MNDR hsa-miR-205-5p Skin melanoma MNDR-E-MI-27214
MNDR hsa-miR-205-5p Colorectal cancer MNDR-E-MI-27215
MNDR hsa-miR-205-5p Nasopharyngeal carcinoma MNDR-E-MI-27216
MNDR hsa-miR-205-5p Nasopharynx carcinoma MNDR-E-MI-27217
MNDR hsa-miR-205-5p Multiple myeloma MNDR-E-MI-27218
MNDR hsa-miR-205-5p Ovarian epithelial cancer MNDR-E-MI-27219
MNDR hsa-miR-205-5p Esophageal squamous cell carcinoma MNDR-E-MI-27220
MNDR hsa-miR-205-5p Uterine cervical neoplasms MNDR-E-MI-27221
MNDR hsa-miR-205-5p Nasopharyngeal cancer MNDR-E-MI-27222
MNDR hsa-miR-205-5p Cerebral hemorrhage traumatic MNDR-E-MI-27223
MNDR hsa-miR-205-5p Intracranial hemorrhage hypertensive MNDR-E-MI-27224
MNDR hsa-miR-205-5p Barrett's carcinogenesis MNDR-E-MI-27225
MNDR hsa-miR-205-5p Breast cancer her3+ negative MNDR-E-MI-27226
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ABCC2 Homo sapiens RR00023539
TOP